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 Introduction 
 Depression is among the most frequent mental disor-
der after stroke, with an estimated prevalence of 30%  [1] . 
Due to its high frequency and a presumed specific etiol-
ogy, a proper term has been coined for the phenomenon: 
poststroke depression (PSD). Counted among the major 
malign long-term sequelae of stroke, PSD is associated 
with prolonged recovery  [2] and an increased risk of re-
current and fatal stroke  [3] .
 The frequency of PSD increases in lockstep with stroke 
prevalence. Due to demographic changes, the number of 
stroke events in Europe is projected to increase from 1.1 
million per year in 2000 to 1.5 million in 2025  [4] . Thanks 
to advances in emergency medicine and acute care, the 
number of stroke survivors has consistently increased 
over the past 3 decades  [5] . Currently, two thirds of all 
cases survive stroke, yet half of these survivors suffer from 
persisting impairment  [6] . In one third of the survivors, 
quality of life is additionally reduced by a depressive dis-
order  [7] .
 Despite these facts, our knowledge about PSD is still 
fragmentary. Research is complicated by long periods of 
incidence amounting up to 2 years after stroke, by inter-
mittent exacerbation of PSD, and by changes of care pro-
viders when proceeding from acute to stationary or ambu-
lant care  [8] . However, these obstacles are not unique to 
PSD, but shared by many psychiatric complications of 
chronic or life-threatening diseases, e.g. in multiple sclero-
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sis or cancer, and should not prevent us from developing 
procedures for early identification and effective treatment. 
A pathogenetic model involving the whole period of inci-
dence is the starting point for this endeavor. The present 
paper will review pathogenetic models proposed in the 
1980s and 1990s. Based on these earlier approaches and on 
longitudinal research published since that time, a two-
phase model is proposed that reflects the current knowl-
edge about the emergence of PSD. Finally, possible impli-
cations of the model are outlined for research and practice.
 Dualistic Models of the PSD Pathogenesis 
 Early concepts of PSD were oriented towards a dual-
ism of organic and ‘endogenous’ psychiatric disease 
( fig. 1 ). Based on the findings of their pioneering longitu-
dinal study, the Baltimore research group postulated two 
different syndromes  [9, 10] . A mild depressive syndrome 
similar to the DSM-IV diagnosis ‘minor depression’ was 
thought to be related to organic factors and to persist as a 
chronic ‘poststroke depression’ condition after 2 years. In 
contrast, a more severe initial syndrome similar to ‘major 
depression’, associated with lesions in the left frontal cor-
tex and underlying basal ganglia, was thought to be tem-
porary or ‘reactive’ and to disappear within 2 years after 
stroke. This dual syndrome hypothesis was challenged by 
later prospective longitudinal research, revealing a con-
siderable number of cases with persisting major depres-
sion or short-lived minor depression syndromes as well 
as later onset of major depression  [11, 12] .
 Later concepts of PSD rather focused on the sequential 
evolvement of PSD in different critical periods within 2 
years after stroke  [13] . Herrmann and Wallesch  [14] re-
lated these stages to the three typical rehabilitation phas-
es: acute, postacute, and chronic phase (after discharge). 
They proposed that in the acute phase after stroke, PSD 
would be related to primary factors, such as premorbid 
disposition, lesion site, and configuration. Later on, dur-
ing postacute rehabilitation, when the patients realize 
that their impairments may be long-lasting or even per-
manent, secondary psychological factors, such as coping 
style, would gain in importance. After discharge from the 
rehabilitation center, reintegration into the social envi-
ronment, involving a change of roles from being a patient 
to being ‘disabled’, was proposed as the tertiary factor that 
might trigger depression. Despite the distinction of three 
phases, the dualism of ‘organic’ and ‘psychosocial’ factors 
was kept by the model, as the authors proposed a progres-
sion from organic to psychosocial risk factors that could 
trigger PSD.
 Gainotti et al.  [12] tested the central predictions of 
both models in their longitudinal study sample. First, 
they found that the symptom profiles of patients classi-
fied as having PSD were very similar at 2, 4, and 6 months 
after stroke, but differed from a control sample with ma-
jor depression without stroke. In PSD patients, symptoms 
of anxiety, catastrophic reactions, hyperemotionalism, 
and diurnal mood variations were more frequent, where-
as in the ‘nonorganic’ major depression sample, depressed 
mood, guilt feelings, and suicidal thoughts were more fre-
quent. This finding argued against the two-syndrome hy-
Persistent depressive
disorder‘Dysthymia’Organic factors
X‘Major depression’
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 Fig. 1. Schematic illustration of existing 
dualistic models of PSD pathogenesis. 
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pothesis. As a second finding, Gainotti et al.  [12] found 
no significant relationship between lesion location, pres-
ence of PSD, and time elapsed since stroke, which was not 
in line with the assumptions of the model of Herrmann 
and Wallesch  [14] .
 Review of Prospective Longitudinal Research 
 Our review of the literature involved prospective lon-
gitudinal studies available in the MEDLINE and PUBMED 
databases between 1987, the year in which the first longi-
tudinal data on PSD by Robinson et al.  [9] appeared, and 
January 1, 2014. Key words were ‘stroke’ AND ‘depress’ 
AND ‘prospective longitudinal’. In case of multiple pa-
pers on the same project, only the main publication was 
selected for each study. The references of each study were 
checked for citations of further studies in this field. Stud-
ies were selected if they fulfilled the following criteria: 
(a) an initial sample of at least 80 stroke patients included 
in the study, (b)  ≥ 2 assessments of depression within the 
first 2 years after stroke, and (c) reporting the rates of 
stroke patients that fulfilled clinical consensus criteria of 
depression (ICD-10; DSM-IV) or ranged above a com-
monly accepted cutoff in a depression questionnaire. 
Studies that reported group means in depression ques-
tionnaires without distinguishing between subclinical 
symptoms and depressive disorder were not included. 
Ten prospective longitudinal studies fulfilled these crite-
ria for PSD  [8, 9, 13, 15–21] . The rates of patients classi-
fied as depressive were pooled and averaged across stud-
ies, so that the resulting mean rates were weighted ac-
cording to the sample size. A total of 2,641 patients were 
considered in this review. The resulting mean of depres-
sion rates showed a biphasic pattern, with a rise in depres-
sive symptoms within the first 6 months after stroke, 
which drops slightly around 12 months, and rises again 
within the second year after stroke ( fig. 2 ).
 It should be noted that our overview of studies is ex-
ploratory and limited in several aspects. First, most of the 
considered studies are hospital- or rehabilitation-based 
rather than community-based. Thus, they may be selec-
tive, as not all stroke patients may be treated in institu-
tions, and as depression may be assessed relatively late in 
the course of the disease  [22] . As a further aspect of selec-
tivity, which is very common in studies on PSD, patients 
with aphasia might be underrepresented, as the question-
naires used here were all based on verbal reports.
 Our review is further limited by large methodological 
variations between the studies. Although we attempted to 
control for different sample sizes by weighting the mean 
PSD rates, the employed diagnostic procedures also var-
ied largely. In addition, the initial sample sizes were not 
overly large, i.e. around 100 in most of the studies, and 
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 Fig. 2. Overview of PSD rates in 11 prospective longitudinal stud-
ies of stroke survivors (n >80, at least 2 assessments) from 1987 to 
2013, with a total sample size of 2,641 patients. The thick black line 
represents mean depression rates weighted according to the sam-
ple size. MADRS = Montgomery-Åsberg Depression Rating Scale; 
CES-D = Center for Epidemiological Studies Depression Scale; 
BDI = Beck Depression Inventory; Cornell_spo = Cornell Scale, 
filled in by spouses. 
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further diminished in the course of the study due to high 
comorbidity, mortality, and a shift of living conditions in 
stroke patients, resulting in dropout rates of around 30% 
per year. Moreover, only one of the reviewed studies  [17] 
reported depression rates at 18 months after stroke. Thus, 
the decrease in prevalence rates from nearly 30% at 12 
months to <20% at 18 months relies on restricted data. 
However, even if disregarding the 18 months’ data point, 
there is a slight decline in prevalence rates between 6 and 
12 months based on multiple large studies. However, this 
trend does not continue to decrease until 24 months after 
stroke, but is, even without the 18 months’ data point, 
compatible with the view that a second cluster of risk fac-
tors may increase prevalence rates during the second year 
after stroke. Despite these limitations, it is notable that the 
overall pattern emerging from these studies is biphasic, 
with a second rise in the second year after stroke, which 
may reflect problems of adjustment as proposed by Herr-
mann and Wallesch  [14] . 
 Risk Factors for PSD 
 To explore the pathogenesis of PSD, a large number of 
potential risk factors have been examined over the past 30 
years. Demographic, stroke-related, premorbid, psycho-
social, and neurobiological factors were investigated for 
associations with PSD. Reviewing the existing literature, 
Hackett and Anderson  [1] counted no less than 87 inves-
tigated predictors. They identified 4 major variables that 
had been investigated in at least 5 studies and consistent-
ly proved to be predictors of later depression: physical 
disability, stroke severity, cognitive impairment, and psy-
chosocial factors, such as social support after stroke. Evi-
dence regarding demographic variables, such as older age 
and female gender, was divided at that point in time.
 Regarding the pathogenetic models of PSD, Hackett 
and Anderson  [1] found that most studies provided rather 
explanatory than predictive models. Concluding that no 
reliable data were available to allow an easy identification 
of patients with depression after stroke, they emphasized 
the importance of predictive models, which permit to esti-
mate the risk of later depression on the basis of acute or 
postacute variables. Finally, they recommended additional 
research in this area, ‘not only in terms of increasing our 
understanding of etiological risk factors for depression in 
the setting of stroke but also in advancing health care de-
livery to improve stroke rehabilitation outcomes’  [1] .
 Since then, several longitudinal studies have been pub-
lished, such as the large Italian DESTRO study  [23] , reac-
tualizing the importance of the female gender, the history 
of depression, and the history of stroke as risk factors, and 
the Sydney Study  [24] , emphasizing the importance of 
apathy. Also, as an interesting and rarely considered fac-
tor, Storor and Byrne  [25] revealed that premorbid per-
sonality affected the risk of PSD.
 Demographic Risk Factors 
 The impact of demographic risk factors on PSD is con-
troversial and may be less pronounced than in other men-
tal diseases. The female gender, although examined in 
most studies, was sometimes identified as a risk factor, 
but rather than being clearly related to PSD, it was linked 
to depressive disorders in general. Age <65 years was by 
some, but not all, studies identified as a predictor of PSD, 
a finding which was explained by differences in the occu-
pational status, as younger people’s lives might be more 
affected than that of retired patients  [10] . This explana-
tion, together with the varying pattern found in the lit-
erature, suggests that demographic factors might not act 
as independent predictors, but as mediators for other risk 
factors  [9] .
 Premorbid Risk Factors 
 Several premorbid health conditions, such as a history 
of depressive disorder as well as a history of stroke or car-
diovascular disease, are well-established risk factors for 
PSD  [26] . Others, such as personality and coping skills 
 [27] or premorbid neurobiological risk factors, are often 
recommended for future research  [28] , but are not yet 
fully understood. 
 Stroke-Related Risk Factors 
 Stroke-related factors include all factors directly relat-
ed to cerebral damage caused by the ischemic or hemor-
rhagic event. There is no evidence of a significant influ-
ence of the stroke type. Location of the lesion in terms of 
the hemisphere in which the stroke occurred has been 
controversially discussed. While initial research on PSD 
reported evidence of a higher PSD risk in left-hemisphere 
stroke  [9] , this has not been supported by the majority of 
studies according to more recent large-scale reviews  [1] . 
It has been proposed that specific lesions such as the dis-
ruption of frontostriatal circuits may be associated with 
PSD  [29] . To date, evidence for more specific hypotheses 
on lesion localization has been limited by methodological 
diversity across studies  [22] .
 Under the topic of ‘stroke-related risk factors’, many 
studies also subsume the degree of impairment, often es-
timated by impairments of activities of daily living, as well 
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as cognitive impairment, language impairment, or ne-
glect. Although these risk factors have often been ad-
dressed, their relationship with depression is far from 
definite  [30] , which suggests the presence of mediators 
and moderators. 
 Psychosocial Risk Factors 
 Several psychosocial risk factors, such as the amount 
of social support perceived by the patient, might affect the 
level of depressive symptoms already in early phases after 
stroke  [31] . Nevertheless, these factors might also predict 
PSD in later time periods, when reintegration into every-
day life is relevant  [26, 32] .
 A Two-Phase Model of PSD Pathogenesis 
 Integrating the sequential evolvement hypothesis and 
the current knowledge about risk factors, we propose a 
two-phase model of PSD pathogenesis. As displayed in 
 figure 3 , the model distinguishes between an early and a 
late period, in which depressive disorders likely emerge. 
In accordance with recent studies analyzing longitudinal 
data with hierarchical regression methods, the model 
postulates partly dissociable sets of risk factors for early- 
and late-onset depressiveness. However, these factors are 
not grouped in a dualistic way. While the influence of 
stroke-related factors is not restricted to the first months 
after stroke, psychosocial factors may exert their influ-
ence not only in later phases  [21, 33] but also within the 
first weeks after stroke  [31] .
 Regarding phase 1, early-onset depressiveness in the 
first weeks after stroke is, according to the literature, as-
sociated with stroke-related factors, such as functional 
impairments due to motor or language deficits. Our mod-
el additionally emphasizes the role of premorbid factors. 
Especially neurobiological factors, such as a preactivated 
stress system, and psychological premorbid factors, such 
as self-concept or self-efficacy beliefs, have often been 
proposed  [26, 32, 34] but rarely considered in large lon-
gitudinal studies. Notably, early-onset depressiveness it-
self represents an important predictor of later, persisting 
depressive disorders  [35] .
 In phase 2, about 1 year after stroke, most patients have 
finished rehabilitation programs, but are typically still in-
volved in a long-term reintegration process, and are prob-
ably confronted with their persisting impairments. Activ-
ity of daily living impairment is still a major determinant 
of depression in this late phase. However, the relationship 
with depression is seemingly not unitary, but mediated by 
coping skills and the degree of social integration  [25] . Pa-
tients who experience their daily lives as stressful and find 
it difficult to adapt to their environment are at a higher 
risk of depression  [36] .
 Although our model as a whole is in line with the cur-
rent knowledge on PSD risk factors, it does not reflect the 
findings of every study in the field. One obvious reason 
may be the large variation of the study samples, ranging 
from slightly impaired clients of outpatient wards to se-
verely impaired patients in rehabilitation clinics. A fur-
ther source of variance is the above-mentioned diversity 
of syndromes and impairments following stroke. Despite 
Phase 1
Risk factors
- Stroke severity
- Location of lesion
- Motor/cogn. impairment
- Social support
Premorbid
vulnerability
- History of stroke
- History of
  mental disorder
- Genetics
- Self-concept
Phase 2
Risk factors
- Younger age
- Dysfunctional coping
- Poor social integration
- Phase 1 depression
Stroke 1M 6M 12M 24M
Months after stroke
 Fig. 3. Proposed two-phase pathogenetic 
model of depression after stroke (PSD). 
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these limitations, it is remarkable that the above-reported 
pattern emerging from the literature is complemented by 
the clinicians’ observation of a late ‘second rise’ of depres-
sion  [17] , which seems less closely related to stroke sever-
ity than early-onset depressiveness  [37] .
 Implications of the Model 
 The primary aim of our two-phase model was to inte-
grate the existing knowledge on the PSD risk factors in 
order to stimulate further longitudinal research and to 
provide a basis for the development of preventive and 
therapeutic strategies. In the following section, we will 
outline the most important implications for research and 
practice. First, with regard to prospective longitudinal re-
search in general, there is a need for more studies involv-
ing large consecutive hospital-based sampling. Pure reg-
ister-based studies may have been valuable in the past, but 
as the main groups of risk factors are well confirmed now, 
the time is ripe to generate hypothesis-driven designs 
with consecutive assessments. These assessments should 
include the supposed ‘intermediate’ phase between 6 and 
18 months and long-term follow-ups of at least 2 years. 
The change of health care providers and the high rate of 
dropouts is a serious problem and should be combatted 
with any means, especially those developed in successful 
epidemiological research. 
 Second, as formulated by a recent review on the pre-
dictors of depression after stroke  [21] , the proposed sets 
of risk factors should be validated by regression-based 
statistical methodology  [33] . These methods require 
large longitudinal data sets, but with refined methodol-
ogy, the stroke- and age-typical variability is not limited 
by multiple selection criteria to the same extent  [38] , but 
can be statistically controlled by carefully selected and 
standardized descriptive parameters, such as scales mea-
suring initial stroke severity. Third, parameters of pre-
morbid neurobiological and self-concept-related risk 
factors as well as indicators of patient-environmental fit, 
often proposed as promising candidates, should be fur-
ther explored. Together with these research activities, 
our model may contribute to proceed from accumulating 
findings on relevant risk factors towards the identifica-
tion of time-bound sets of risk factors, which may inter-
act with each other. Specific combinations of risk factors 
may be linked to PSD exacerbation in different time win-
dows.
 Knowledge of these predictor sets may allow for better 
targeting of interventions for preventing, treating and 
managing depression after stroke. For example, a past 
history of depression, one of the well-confirmed premor-
bid factors in the model, should be part of the routine as-
sessment in acute neurology, in the same way as a history 
of prior strokes or transitory ischemic attacks. Another 
premorbid factor, i.e. self-concept and coping strategies, 
suffers from heterogeneity and limited availability of eco-
nomical standardized assessment tools. Such measures 
should be developed. Their results, for example a prefer-
ence for a certain way of coping, can be documented in 
the reports handed over to postacute or ambulant treat-
ment. 
 In phase 1, further preventive strategies should be es-
tablished. First, as depressive symptoms have proven to 
be predictive of later depressive disorders  [39] , these de-
pressive symptoms should be assessed and documented. 
Special attention should be given to the assessment of 
aphasic patients in this context  [40] . The finding that the 
self-perceived degree of social support and satisfaction 
with care seems to already be crucial in this phase  [41] 
should be incorporated in the education of health profes-
sionals and in the counseling of caregivers and relatives. 
Also, there is an urgent need for intervention studies 
with pharmacological or nonpharmacological agents. 
Notably, although in depression  without  stroke it is the 
combination of both strategies that has proven most 
promising, there are no studies on combination therapy 
in PSD. The recent increased prescription of selective se-
rotonin reuptake inhibitors in stroke is based on a study 
indicating better rehabilitation results in medicated 
stroke patients  [42] , but the mechanisms of this effect are 
not yet understood, and unwarranted bi-effects of anti-
depressants in nondepressive stroke patients are under-
explored.
 Finally, in phase 2 ambulant therapy, integration is 
the central topic. More studies including at least 2-year 
follow-ups should be conducted. Similar to research on 
resilience, predictors of successful reintegration and 
successful prevention of PSD should be explored, in ad-
dition to examining those patients suffering from PSD.
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